Treatment of Acute Drug-Induced Psychoses, Associated with Modern Synthetic Psychoactive Substances

Use of new synthetic drugs (synthetic cannabinoids — “spices”, synthetic psychostimulants — “salts”, synthetic GABA-agonists — “butyrates”) is associated with a high risk of psychoses. Nowadays there are no evidence-based guidelines for treatment of these psychotic disorders. Objective: to develop effective therapeutic strategies for the treatment of acute substance-induced psychoses associated with modern synthetic drugs. Material and methods: 96 patients with substance-induced psychoses associated with synthetic cannabinoids (n = 32), synthetic psychostimulants (n = 33), and synthetic GABA-agonists (n = 31) were examined. In these groups we estimated effectiveness of different combination therapy: desintoxication and benzodiazepine, desintoxication and benzodiazepine and haloperidol, desintoxication, benzodiazepine and phenibut. The following methods were used: clinical-psychopathological, laboratory, statistics. Results: сomparative efficacy of therapeutic strategies differed in three investigated groups. In psychoses associated with synthetic cannabinoids the most effective strategy was haloperidol add-on. Differences between treatment approaches in group of psychostimulants-induced psychoses were not found. In psychoses associated with synthetic GABA-agonists the most effective strategy was phenibut add-on. Conclusion: the choice of effective therapeutic intervention in drug-induced psychosis should be based on type of synthetic drug.

1. Koshkina EA. Zabolevaemost' psikhicheskimi i povedencheskimi rasstroystvami, svyazannymi s upotrebleniem psikhoaktivnykh veshchestv, v Rossiyskoy Federatsii v dinamike za 5 let. Voprosy narkologii. 2011;1:17-27,129. (In Russ.).

2. Pleshakov AA, Cherkudinov DA. O narkoticheskih svoistvah oksibutirata natriya i ego nemedicinskom ispolzovanii. Prikladnaya toksikologiya. 2012;7:36-40. (In Russ.).

3. Schifano F, Orsolini L, Duccio Papanti G, Corkery JM. Novel psychoactive substances of interest for psychiatry. World Psychiatry. 2015;14(1):15-26. doi: 10.1002/wps.20174 PMID: 25655145; PMCID: PMC4329884

4. Livanov GA, Lodyagin AN, Kaziahmedov VA, Pochinyaeva LM, Glushkov SI, Batocirenov BV, Kovalenko AL. Klinicheskii sluchai ostrogo tyazhelogo otravleniya 1,4-butandiolom devochki-podrostka. Anesteziologiya i reanimatologiya. 2017;62(4):297-300. (In Russ.). doi: 10.18821/0201-7563-2017-62-4-297-300

5. Usov GM, Rakitin SA. Clinical structure of psychoses, associated with use of modern synthetic psychoactive substances Neurology Bulletin; 2020;2:40-45. (In Russ.). doi: 10.17816/nb34041

6. Bokhan NA, Selivanov GYu. Klinicheskaya tipologiya psikhopatologicheskikh rasstroystv u potrebiteley sinteticheskikh kannabinoidov (spaysov). Sibirskiy vestnik psikhiatrii i narkologii. 2015;4:18-23. (In Russ.).

7. Stijnenbosch PJ, Zuketto C, Beijaert PJ, Maat A. Onthoudingsdelier na het gebruik van GHB [GHB withdrawal delirium]. Ned Tijdschr Geneeskd. 2010;154:A1086. Dutch. PMID: 20132572

8. Bokhan NA, Selivanov GYu, Salnikov AA, Blonsky KA. Mental Disorders Associated with the Abuse of Synthetic Cannabinoids (Spices). Psychiatry (Moscow) (Psikhiatriya). 2021;19(2):6-16. (In Russ.). doi: 10.30629/2618-6667-2021-19-2-6-16

9. Rakitin SA, Usov GM. Typology of psychotic disorders, associated with modern synthetic psychoactive substances. Psihiatriya i psihofarmakoterapiya. 2020;6:31-36. (In Russ.).

10. Stiles BM, Fish AF, Cook CA, Silva V. Bath Salt-Induced Psychosis: Nursing Assessment, Diagnosis, Treatment, and Outcomes. Perspect Psychiatr Care. 2016;52(1):68-78. doi: 10.1111/ppc.12101 Epub 2015 Jan 26. PMID: 25624142

11. Penders TM, Gestring RE, Vilensky DA. Intoxication delirium following use of synthetic cathinone derivatives. Am J Drug Alcohol Abuse. 2012;38(6):616-617. doi: 10.3109/00952990.2012.694535 Epub 2012 Jul 11. PMID: 22783894

12. Kekelidze ZI, Klimenko TV, Kozlov AA, Shakhova SM. Lechenie ostrogo psikhoza vsledstvie upotrebleniya sinteticheskikh kannabinoidov. Sibirskij vestnik psikhiatrii i narkologii. 2017;3:16-20. (In Russ.).

13. Kamal RM, van Noorden MS, Wannet W, Beurmanjer H, Dijkstra BA, Schellekens A. Pharmacological Treatment in Y-Hydroxybutyrate (GHB) and Y-Butyrolactone (GBL) Dependence: Detoxification and Relapse Prevention. CNS Drugs. 2017;31(1):51-64. doi: 10.1007/s40263-016-0402-z PMID: 28004314

14. Dubatova IV, Stoyakin IV, Karnaukh KA, Safronenko AV. Structural-dynamic analysis of clinical manifestations and features of psychotic disorders therapy in users of “designer” drugs. Siberian Herald of Psychiatry and Addiction Psychiatry. 2018;1(98):36-41. (In Russ.). doi: 10.26617/1810-3111-2018-1(98)-36-41

15. Ivanec NN, Anohina IP, Vinnikova MA. Narkologiya: nacionalnoe rukovodstvo. M.: GEOTAR-Media, 2008. (In Russ.).

16. Pyatnickaya IN. Obshchaya i chastnaya narkologiya: rukovodstvo dlya vrachej. M.: Medicina, 2008. (In Russ.).

17. Bokhan NA, Usov GM, Rakitin SA. Dynamics of the psychopathological picture of psychosis developed in the background of the consumption of modern synthetic psychoactive substances. Voprosi narkologii. 2021;8:5-22. (In Russ.). doi: 10.47877/0234-0623_2021_08_5

18. Rakitin SA, Usov GM. Sposob lecheniya abstinentnogo sindroma, s celyu prevencii razvitiya psihoza u lic s zavisimostyu ot sinteticheskih agonistov receptorov gamma-aminomaslyanoi kisloti: butirolaktona, 1,4-butandiola. Pat. 2739192 Rossiiskaya Federaciya, MPK A 61 K 31/197, A61 R 25/30., zayavitel i patentoobladatel FGBOU VO OmGMU Minzdrava Rossii № 2020120123/04; zayavl. 18.06.2020; opubl. 21.12.2020, Byul. № 36. 7 s. (In Russ.).

19. Belousov YuB, Moiseev VS, Lepahin VK. Klinicheskaya farmakologiya i farmakoterapiya: rukovodstvo dlya vrachei. M.: Universum publishing, 1997. (In Russ.).

20. Liao PC, Chang HM, Chen LY. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol. J Formos Med Assoc. 2018;117(12):1124-1127. doi: 10.1016/j.jfma.2018.06.005 Epub 2018 Jun 19. PMID: 29933901

21. Bryun EA, Agibalova TV, Bedina IA, Buzik OZh, Vinnikova MA, Koshkina EA, Mihajlov MA, Nadezhdin AV, Tetenova EYu. Psihicheskie i povedencheskie rasstrojstva, vyzvannye upotrebleniem psihoaktivnyh veshchestv. Psihoticheskoe rasstrojstvo. Klinicheskie rekomendacii. Proekt. Narkologiya. 2019;18(7):6-20. (In Russ.). doi: 10.25557/1682-8313.2019.07.6-20

22. Klinicheskie rekomendacii po diagnostike i lecheniyu psihicheskih rasstrojstv i rasstrojstv povedeniya, svyazannyh s upotrebleniem psihoaktivnyh veshchestv (MKB-10 F10-19), i reabilitacii bol'nyh narkologicheskogo profilya. M.: Associaciya narkologov Rossii. 2014. (In Russ.).